Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
ELAN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.03 - $18.80
Previous CloseN/A
Volume2.53M
Average Volume (3M)4.53M
Market Cap
$5.21B
Enterprise Value$11.18B
Total Cash (Recent Filing)$468.00M
Total Debt (Recent Filing)$4.32B
Price to Earnings (P/E)15.5
Beta1.69
Next Earnings
May 13, 2025EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.68
Shares Outstanding494,613,950
10 Day Avg. Volume3,974,317
30 Day Avg. Volume4,526,488
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.17
Price to Cash Flow (P/CF)7.40
P/FCF Ratio10.50
Enterprise Value/Market Cap2.15
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.86
Enterprise Value/Ebitda22.49
Forecast
1Y Price Target
$15.33Price Target Upside43.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Debt ManagementCompany paid down 25% of its debt in 2024 to reach 4.3x leverage versus 5.6x in 2023.
Product InnovationInnovation Product sales are expected to be driven by Credelio Quattro and Experior, showing a significant increase.
Revenue GrowthStrong revenue growth for Pet Health is anticipated to offset some challenges in Farm Animal sales.
Bears Say
Earnings GuidanceThe updated 2025 earnings guidance is below market expectations.
Earnings PerformanceA decline in EPS is projected due to gross margin headwinds and a higher tax rate.
Foreign Exchange ImpactFX remains a major headwind for ELAN, with an expected drag of $45mn on Adj EBITDA, $110mn on revenue, and 7c on Adj EPS.
---
Ownership Overview
0.74% Insiders
44.55% Mutual Funds
1.13% Other Institutional Investors
39.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $10.03 and its highest was $18.80 in the past 12 months.
What is Elanco Animal Health’s market cap?
Elanco Animal Health’s market cap is $5.21B.
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is May 13, 2025 which is in 48 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Feb 25, 2025. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.149 by -$0.009.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is 0.31.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 494,613,950 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.14 in its last earnings report, missing expectations of $0.149. Following the earnings report the stock price went down -3.69%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Currently, no hedge funds are holding shares in ELAN
---
Elanco Animal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.33 (43.41% Upside)
$15.33 (43.41% Upside)
Blogger Sentiment
Bullish
ELAN Sentiment 60%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 3.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $483.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 12.9%
Last 30 Days ▼ 12.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.39%
12-Months-Change
Fundamentals
Return on Equity
5.49%
Trailing 12-Months
Asset Growth
-12.17%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
---
ELAN Company Deck
---
ELAN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and successful debt reduction, driven by innovation and strategic execution in both Pet Health and Farm Animal segments. However, the call also acknowledged challenges due to foreign exchange headwinds and slower than expected adoption of certain products. Overall, the sentiment was cautiously optimistic, with a focus on continued growth and innovation.Read More>---
ELAN Stock 12 Month Forecast
Average Price Target
$15.33
▲(43.41% Upside)
Technical Analysis
Best Analysts Covering ELAN
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
+7.14%
reiterated a sell rating 11 months ago
Copying Nathan Rich's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +7.14% per trade.
---